Clinical Characteristics of Neovascular Glaucoma (NCT07177807) | Clinical Trial Compass
CompletedNot Applicable
Clinical Characteristics of Neovascular Glaucoma
China400 participantsStarted 2018-01-01
Plain-language summary
The goal of this observational study is to explore the clinical characteristics of patients with neovascular glaucoma (NVG), and to analyze the relationship between NVG and various underlying diseases, ocular conditions, lifestyle, inflammatory markers, and treatment response. To systematically analyze the clinical data of NVG patients with different types of primary disease, further reveal the different clinical characteristics of NVG patients with different primary disease, and describe the selection of treatment methods in recent years, in order to provide more scientific basis for clinical treatment.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients who met the diagnostic criteria for NVG.
Exclusion Criteria:
* Patients with incomplete clinical data and information.
* Severe systemic diseases (such as chronic renal failure requiring dialysis, severe neurological diseases, immune diseases), pregnancy or lactation.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
visual acuity
Timeframe: Time Frame: Pre-operative, post-operative follow-up at 1 month, 3 months, 6 months, 1 year, etc.
2
intraocular pressure
Timeframe: Time Frame: Pre-operative, post-operative follow-up at 1 month, 3 months, 6 months, 1 year, etc.